PYTHON Study The PYTHON Study (NCT04734184) was a Phase III, European, multicenter, prospective cross-over trial, to evaluate and compare the detection rates, impact on patient management and safety ...
Submission follows the completion of Phase III PYTHON clinical trial of [18F]-DCFPyL for recurrent prostate cancer in Europe in May 2022 Phase III PYTHON clinical trial results to be presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results